Goji Berry Extract (50% Polysaccharides) standardized to 50% polysaccharides is a goji/wolfberry extract typically produced from Lycium barbarum. “50% polysaccharides” generally indicates standardization so that ~half of the extract is measured as Lycium barbarum polysaccharides (LBP), a heterogeneous group of complex carbohydrates studied for immunomodulatory and antioxidant-related effects. Because “polysaccharides” are not a single defined molecule, different suppliers may vary in the polysaccharide profile and test method; interpret research as product‑ and assay‑dependent rather than universally transferable.

*Doses vary substantially between whole berries, juice preparations, and extracts. Prefer products with declared standardization and consistent assay; interpret benefits as product‑ and dose‑dependent rather than universal. See systematic review overview.

Mechanistic highlights

1. Pattern‑recognition signaling: LBP are studied for interacting with immune pattern‑recognition pathways and downstream cytokine programs (context‑dependent immunomodulation).
2. Oxidative‑stress handling: Preclinical models commonly report reductions in oxidative stress readouts and improved antioxidant enzyme activity consistent with “antioxidant support” signaling.
3. Metabolic inflammation axis: Reported effects on lipid/glucose markers may relate to inflammation modulation and gut‑immune crosstalk, but clinical effects are heterogeneous.

Safety & practical use

• Usual supplemental range: 300–1,200 mg/day for standardized extracts (adjust to label and local regulatory guidance).
• Upper-dose tolerance: GI upset can occur at higher intakes; reduce dose if discomfort occurs.
• Drug interactions: Avoid with warfarin/anticoagulants unless supervised (case reports of increased INR). See PubMed.
• Glucose-lowering additivity: If using diabetes medications, monitor glucose closely when adding goji products.
• Allergy risk: Rare allergic reactions have been reported; discontinue if symptoms occur. See PubMed.